RATIONALE: Lungs of adult mice exposed to hyperoxia as newborns are simplified and exhibit reduced function much like that observed in people who had bronchopulmonary dysplasia (BPD) as infants. Because survivors of BPD also show increased risk for symptomatic respiratory infections, we investigated how neonatal hyperoxia affected the response of adult mice infected with influenza A virus infection. OBJECTIVES: To determine whether neonatal hyperoxia increased the severity of influenza A virus infection in adult mice. METHODS: Adult female mice exposed to room air or hyperoxia between Postnatal Days 1 and 4 were infected with a sublethal dose of influenza A virus. MEASUREMENTS AND MAIN RESULTS: The number of macrophages, neutrophils, and lymphocytes observed in airways of infected mice that had been exposed to hyperoxia as neonates was significantly greater than in infected siblings that had been exposed to room air. Enhanced inflammation correlated with increased levels of monocyte chemotactic protein-1 (CCL2) in lavage fluid, whereas infection-associated changes in IFN-gamma, IL-1beta, IL-6, tumor necrosis factor-alpha, KC, granulocyte-macrophage colony-stimulating factor, and macrophage inflammatory protein-1alpha, and production of virus-specific antibodies, were largely unaffected. Increased mortality of mice exposed to neonatal hyperoxia occurred by Day 14 of infection, and was associated with persistent inflammation and fibrosis. CONCLUSIONS: These data suggest that the disruptive effect of hyperoxia on neonatal lung development also reprograms key innate immunoregulatory pathways in the lung, which may contribute to exacerbated pathology and poorer resistance to respiratory viral infections typically seen in people who had BPD.
RATIONALE: Lungs of adult mice exposed to hyperoxia as newborns are simplified and exhibit reduced function much like that observed in people who had bronchopulmonary dysplasia (BPD) as infants. Because survivors of BPD also show increased risk for symptomatic respiratory infections, we investigated how neonatal hyperoxia affected the response of adult mice infected with influenza A virus infection. OBJECTIVES: To determine whether neonatal hyperoxia increased the severity of influenza A virus infection in adult mice. METHODS: Adult female mice exposed to room air or hyperoxia between Postnatal Days 1 and 4 were infected with a sublethal dose of influenza A virus. MEASUREMENTS AND MAIN RESULTS: The number of macrophages, neutrophils, and lymphocytes observed in airways of infected mice that had been exposed to hyperoxia as neonates was significantly greater than in infected siblings that had been exposed to room air. Enhanced inflammation correlated with increased levels of monocyte chemotactic protein-1 (CCL2) in lavage fluid, whereas infection-associated changes in IFN-gamma, IL-1beta, IL-6, tumor necrosis factor-alpha, KC, granulocyte-macrophage colony-stimulating factor, and macrophage inflammatory protein-1alpha, and production of virus-specific antibodies, were largely unaffected. Increased mortality of mice exposed to neonatal hyperoxia occurred by Day 14 of infection, and was associated with persistent inflammation and fibrosis. CONCLUSIONS: These data suggest that the disruptive effect of hyperoxia on neonatal lung development also reprograms key innate immunoregulatory pathways in the lung, which may contribute to exacerbated pathology and poorer resistance to respiratory viral infections typically seen in people who had BPD.
Authors: Sabine Teske; Andrea A Bohn; Jean F Regal; Joshua J Neumiller; B Paige Lawrence Journal: Am J Physiol Lung Cell Mol Physiol Date: 2005-03-25 Impact factor: 5.464
Authors: Anette M Kunig; Vivek Balasubramaniam; Neil E Markham; Danielle Morgan; Greg Montgomery; Theresa R Grover; Steven H Abman Journal: Am J Physiol Lung Cell Mol Physiol Date: 2005-05-20 Impact factor: 5.464
Authors: M B Hershenson; M K Abe; M D Kelleher; E T Naureckas; A Garland; A Zimmermann; V J Rubinstein; J Solway Journal: Am J Respir Crit Care Med Date: 1994-06 Impact factor: 21.405
Authors: Bradley W Buczynski; Min Yee; B Paige Lawrence; Michael A O'Reilly Journal: Am J Physiol Lung Cell Mol Physiol Date: 2012-03-09 Impact factor: 5.464
Authors: Soumyaroop Bhattacharya; Diana Go; Daria L Krenitsky; Heidi L Huyck; Siva Kumar Solleti; Valerie A Lunger; Leon Metlay; Sorachai Srisuma; Susan E Wert; Thomas J Mariani; Gloria S Pryhuber Journal: Am J Respir Crit Care Med Date: 2012-06-21 Impact factor: 21.405
Authors: Echezona T Maduekwe; Bradley W Buczynski; Min Yee; Tiruamalai Rangasamy; Timothy P Stevens; B Paige Lawrence; Michael A O'Reilly Journal: Pediatr Pulmonol Date: 2014-05-22
Authors: Carole L Marcus; Richard J H Smith; Leila A Mankarious; Raanan Arens; Gordon S Mitchell; Ravindhra G Elluru; Vito Forte; Steven Goudy; Ethylin W Jabs; Alex A Kane; Eliot Katz; David Paydarfar; Kevin Pereira; Roger H Reeves; Joan T Richtsmeier; Ramon L Ruiz; Bradley T Thach; David E Tunkel; Jeffrey A Whitsett; David Wootton; Carol J Blaisdell Journal: Proc Am Thorac Soc Date: 2009-09-15
Authors: Hua Wang; Anjum Jafri; Richard J Martin; Jerry Nnanabu; Carol Farver; Y S Prakash; Peter M MacFarlane Journal: Am J Physiol Lung Cell Mol Physiol Date: 2014-06-20 Impact factor: 5.464
Authors: Jean F Regal; B Paige Lawrence; Alex C Johnson; Sarah J Lojovich; Michael A O'Reilly Journal: Pediatr Allergy Immunol Date: 2014-02-13 Impact factor: 6.377